Hemophilia Drug Alhemo Among 10 New Drugs Set For EU Approval
Novo Nordisk’s Alhemo and Ionis/AstraZeneca’s orphan drug Wainzua are among 10 new medicines that the European Medicines Agency has recommended for pan-EU approval this month.
Novo Nordisk’s Alhemo and Ionis/AstraZeneca’s orphan drug Wainzua are among 10 new medicines that the European Medicines Agency has recommended for pan-EU approval this month.